𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Active Specific Immunotherapy of Human Colorectal Carcinoma with an Autologous Tumor Cell/Bacillus Calmette-Guérin Vaccine

✍ Scribed by MICHAEL G. HANNA Jr.; JANET H. RANSOM; NICHOLAS POMATO; LEONA PETERS; ELISABETH BLOEMENA; JAN B. VERMORKEN; HERBERT C. HOOVER Jr.

Book ID
119869521
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
606 KB
Volume
690
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant immunotherapy treatment of rena
Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized study
✍ Enzo Galligioni; Michele Quaia; Alberto Merlo; Antonino Carbone; Antonella Spada 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

## BACKGROUND. Active specific immunotherapy (ASI) is a strategy that attempts to boost the host's immune response specifically against its own tumor. The purpose of this study was to investigate the effect of adjuvant AS1 in patients with renal carcinoma. ## METHODS. Of 120 consecutive patient

Identification of colon-tumor-associated
Identification of colon-tumor-associated antigens by T-cell lines derived from tumor-infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumor-cell/bacillus calmette-Guérin vaccine
✍ Janet H. Ransom; Barbara A. Pelle; Henk Hubers; Linette M. Keynton; Michael G. H 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 953 KB

## Abstract Tumor immunity developing as a response to an autologous colon‐tumor/bacillus Calmette‐Guerin (BCG) vaccine appears to be associated with induction of CD4 helper T cells, implied by the observation that vaccine efficacy is associated with major histocompatibility complex class‐ll molecu